Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Preclinical pharmacology profile of BMS NEP/ACE inhibitors described

Jan. 8, 1997

Tokyo Tanabe describes agents for cardiovascular/respiratory disorders

Jan. 8, 1997

Beta-blockers underused

Jan. 7, 1997

P&U discontinues development of agent for DVT; Cytel regains development rights

Jan. 7, 1997

Andrx freed to market Dilacor XR bioequivalent

Jan. 3, 1997

bFGF enters clinical trials for PVD

Jan. 3, 1997

T Cell Sciences describes anti-CETP vaccines

Jan. 2, 1997

Nissan Chemical discloses novel cardiovascular agents

Jan. 2, 1997

FDA clears angiotensin II blocker from Ciba

Dec. 31, 1996

Combination antihypertensive product cleared by FDA

Dec. 31, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...